Drug Profile
OT-Etomidate
Latest Information Update: 06 Oct 2006
Price :
$50
*
At a glance
- Originator Anesta Corporation
- Class Anaesthetics; Imidazoles
- Mechanism of Action GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 06 Oct 2006 Discontinued - Phase-II for Anxiety disorders in USA (PO)
- 17 Jan 2001 No-Development-Reported for Anxiety disorders in USA (PO)
- 01 Nov 2000 Anesta has been acquired by Cephalon